AIDS--risk behaviours and AIDS knowledge in intravenous drug users. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS--risk behaviours and AIDS knowledge in intravenous drug users.

N Z Med J. 1987 Apr 8;100(821):209-11. Unique Identifier : AIDSLINE MED/88335059
Robinson GM; Thornton NJ; Rout J; Mackenzie N; Wellington Alcohol and Drug Centre.


Abstract: Surveys of intravenous drug users were undertaken in July 1985 and one year later to assess behaviours which could result in risk of HIV infection and transmission. Ready availability of sterile syringes was reported by 48% in 1986 and 63% in 1985. Sharing of syringes amongst intravenous drug users is a common practice. In 1986, 22% of subjects reported no sharing of syringes, 16% sharing with one and 62% with between 2 and 20 others. There was a significant trend towards less sharing, and improved sterilisation of syringes in 1986. Nearly all subjects were aware of the risks of HIV transmission via shared syringes. In 1985, 19% of subjects reported adopting safer-sex practices compared with 28% in 1986. A history of prostitution was reported by 50% of women. All subjects were aware intravenous drug users had been asked not to donate blood, and none reported having done so within five years. All the subjects tested for HIV antibody were negative.
Keywords: Acquired Immunodeficiency Syndrome/*TRANSMISSION Female Human HIV Seropositivity/EPIDEMIOLOGY Injections, Intravenous Male Narcotic Dependence/*COMPLICATIONS Narcotics/*ADMINISTRATION & DOSAGE Risk Factors Sex Behavior Sterilization/METHODS JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/KWDtransmissionfemalehumanhivseropositivity/epidemiologyinjections,intravenousmalenarcoticdependence/KWDcomplicationsnarcotics/KWDadministration&dosageriskfactorssexbehaviorsterilization/methodsjournalarticle
881230
M88C0632


Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .